NivolumabGrade 3 Hepatitis and grade 4 colitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2032卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70027-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：366 / 366

相关论文

共 50 条

[31] NivolumabGrade 3 diarrhoea: case report
Reactions Weekly, 2022, 1900 (1) : 256 - 256
[32] Belantamab mafodotinGrade 2 and grade 3 keratopathy: 2 case reports
Reactions Weekly, 2023, 1962 (1) : 94 - 94
[33] AntineoplasticsThrombocytopenia and grade 3 peripheral neuropathy: 2 case reports
Reactions Weekly, 2022, 1929 (1) : 77 - 77
[34] IpilimumabAutoimmune colitis: 2 case reports
Reactions Weekly, 2018, 1685 (1) : 114 - 114
[35] SevelamerIschaemic colitis : 2 case reports
Reactions Weekly, 2024, 2019 (1) : 420 - 420
[36] LansoprazoleLymphocytic colitis: 2 case reports
Reactions Weekly, 2008, 1185 (1) : 20 - 20
[37] RofecoxibIschaemic colitis: 2 case reports
Reactions Weekly, 2005, 1068 (1) : 12 - 13
[38] GlycerolIschaemic colitis: 2 case reports
Reactions Weekly, 2021, 1848 (1) : 194 - 194
[39] NivolumabHyperthyroidism and colitis: 2 case reports
Reactions Weekly, 2022, 1918 (1) : 390 - 390
[40] AbataceptUlcerative colitis: 2 case reports
Reactions Weekly, 2014, 1523 (1) : 13 - 13

← 1 2 3 4 5 →